Keyphrases
Maastricht
100%
Intensive Care
100%
Rotational Thromboelastometry (ROTEM)
100%
Coronavirus Disease (COVID)
100%
Non-survivors
80%
Intubation
60%
Survivors
60%
Hemostasis
60%
Tissue Plasminogen Activator (t-PA)
60%
Clotting Time
60%
Hypercoagulability
40%
Fibrinogen
40%
FIBTEM
40%
EXTEM
40%
Intensive Care Unit Mortality
40%
Linear Mixed Model
20%
Age of Onset
20%
Intensive Care Unit
20%
Disease Severity
20%
Lysis Time
20%
Fibrinolysis
20%
Prothrombin Time
20%
Clot
20%
D-dimer
20%
Maximum Clot Firmness
20%
Hypofibrinolysis
20%
Viscoelastic Testing
20%
Lysis
20%
Intensive Care Unit Admission
20%
Competing Risk Survival Analysis
20%
COVID-19
20%
Severe Coronavirus Disease 2019
20%
INIS
patients
100%
mortality
100%
units
100%
biological markers
100%
diseases
75%
tissues
75%
plasminogen
75%
comparative evaluations
50%
trajectories
50%
lysis
50%
fibrinogen
50%
coronaviruses
50%
risks
25%
adjustments
25%
prothrombin
25%
fibrinolysis
25%
dimers
25%
Medicine and Dentistry
Biological Marker
100%
Intensive Care
100%
Thromboelastometry
100%
Intensive Care Unit
80%
Tissue Plasminogen Activator
60%
Intubation
60%
Blood Stasis
60%
Fibrinogen
40%
Hypercoagulability
40%
COVID-19
40%
Disease Severity
20%
Fibrinolysis
20%
D-Dimer
20%
Survival Analysis
20%
Prothrombin Time
20%